☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Boehringer Ingelheim Reports Results of Cyltezo (biosimilar- adalimumab) in P-III VOLTAIRE-X Study for Moderate-to-Severe Chronic...
April 23, 2021
PharmaShots Weekly Snapshots (April 19 - 23, 2021)
April 23, 2021
PharmaShots Interview: Artelo Bio's Dr. Saoirse O'Sullivan Shares Insights on Synthetic Cannabinoid for Cancer Anorexia
April 23, 2021
ADC Therapeutics' Zynlonta (loncastuximab tesirine-lpyl) Receives the US FDA's Approval for the Treatment of R/R Diffuse Large B-C...
April 23, 2021
Vertex Signs a License Agreement with Obsidian Therapeutics to Discover Regulated Gene Editing Therapies
April 23, 2021
Roche Receives the US FDA's Approval for First CDx to Identify Endometrial Cancer Patients Eligible for Immunotherapy
April 23, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions